Fatty acid and phospholipase A2 plasma levels in children with autism
Níveis plasmáticos de ácidos graxos e fosfolipase A2 em crianças com autismo
Márcia Helena Fávero de Souza Tostes; Hudson Caetano Polonini; Rosemeri Mendes; Marcos Antônio Fernandes Brandão; Wagner Farid Gattaz; Nádia Rezende Barbosa Raposo
Abstract
Keywords
Resumo
Palavras-chave
References
Stevens LJ, Zentall SS, Abate ML, Kuczek T, Burgess JR. Omega-3 fatty acids in boys with behavior, learning, and health problems. Pysichol Behav. 1996;59:915-20.
Stevens LJ, Zentall SS, Deck JL, Abate ML, Watkins BA, Lipp SR. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr. 1995;62:761-8.
Richardson AJ, Calvin CM, Clisby C, Schoenheimer DR, Montgomery P, Hall JA. Fatty acid deficiency signs predict the severity of reading and related difficulties in dyslexic children. Prostaglandins Leukot Essent Fatty Acids. 2000;63:69-74.
Richardson AJ. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders. Int Rev Psychiatry. 2006;18:155-72.
Bell JG, Sargent JR, Tocher DR, Dick JR. Red blood cell fatty acid compositions in a patient with autistic spectrum disorder: a characteristic abnormality in neurodevelopmental disorders. Prostaglandins Leukot Essent Fatty Acids. 2000;63:21-5.
Pastural E, Ritchie S, Lu Y, Jin W, Kavianpour A, Khine Su-Myat K. Novel plasma phospholipids biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism. Prostaglandins Leukot Essent Fatty Acids. 2009;81:253-64.
Bell JG, MacKinlay EE, Dick JR, MacDonald DJ, Boyle RM, Glen AC. Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins Leukot Essent Fatty Acids. 2004;71:201-4.
El-Ansary AK, Ben Bacha AG, Al-Ayahdi LY. Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia. Lipids Health Dis. 2011;10:1-8.
Meiri G, Bichovsky Y, Belmaker RH. Omega 3 fatty acid treatment in autism. J Child Adolesc Psychopharmacol. 2009;19:449-51.
Tostes MH, Teixeira HC, Gattaz WF, Brandão MA, Raposo NR. Altered neurotrophin, neuropeptide, cytokines and nitric oxide levels in autism. Pharmacopsychiatry. 2012;45:241-3.
Diagnostic and Statistical Manual of Mental Disorders. 1994.
Brasil MA. Avaliação diagnóstica em psiquiatria da infância e da adolescência. PEC - Programa de Educação Continuada. 2004.
Schopler E, Reichler RJ, Bashford A, Lansing MD, Marcus LM. Psychoeducational Profile Revised (PEP-R). 1990.
Leon V, Bosa C, Hugo C, Hutz CS. Propriedades psicométricas do Perfil Psicoeducaional Revisado: PEP-R. Aval Psicol. 2004;3:39-52.
Folch J, Lees M, Stanley GH. A simple method for the isolation and purification of lipids from animal tissues. J Biol Chem. 1957;226:497-509.
Ross BM, Hudson C, Erlieft J, Warsh JJ, Kish SJ. Increased phospholipid breakdown in schizophrenia: evidence for the involvement of a calcium-independent phospholipase A2. Arch Gen Psychiatry. 1997;54:487-94.
Klin A. Autism and Asperger syndrome: an overview. Rev Bras Psiquiatr. 2006;28:3-12.
Mercadante M, Van der Gaag RJ, Schwartzman JS. Transtornos invasivos do desenvolvimento não-autísticos: síndrome de Rett, transtorno desintegrativo da infância e transtornos invasivos do desenvolvimento sem outra especificação. Rev Bras Psiquiatr. 2006;28:12-20.
Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. J Autism Dev Disord. 2003;33:911-20.
Tostes MH. Transtornos mentais da infância e da adolescência. Ferramentas para descomplicar a atenção básica em saúde mental. 2007:141-74.
Hayaishi O. Molecular mechanisms of sleep-wake regulation: roles of prostaglandins D2 and E2. FASEB J. 1991;5:2575-81.
Kim HY, Akbar M, Lau A, Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3): role of phosphatidylserine in antiapoptotic effect. J Biol Chem. 2000;275:35215-23.
Vreugdenhil M, Bruehl C, Voskuyl RA, Kang JX, Leaf A, Wadman WJ. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci U S A. 1996;93:12559-63.
Bell JG, Miller D, MacDonald DJ, MacKinlay EE, Dick JR, Cheseldine S. The fatty acid compositions of erythrocyte and plasma polar lipids in children with autism, developmental delay or typically developing controls and the effect of fish oil intake. Br J Nutr. 2010;103:1160-7.
El-Ansary AK, Ben Bacha AG, Al-Ayahdi LY. Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis. 2011;10:1-8.
Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol. ;206:198-205.
Gattaz WF, Maras A, Cairns NJ, Levy R, Förstl H. Decreased phospholipase A2 activity in Alzheimer brains. Biol Psychiatry. 1995;37:13-7.
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email